Edition:
United States

Cerus Corp (CERS.OQ)

CERS.OQ on NASDAQ Stock Exchange Global Market

4.27USD
24 Feb 2017
Change (% chg)

$-0.00 (-0.12%)
Prev Close
$4.28
Open
$4.24
Day's High
$4.28
Day's Low
$4.08
Volume
204,361
Avg. Vol
221,818
52-wk High
$7.64
52-wk Low
$3.97

CERS.OQ

Chart for CERS.OQ

About

Cerus Corporation is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates through blood safety segment. The Company's INTERCEPT Blood System is based on its technology for controlling biological replication, and is designed to... (more)

Overall

Beta: 1.88
Market Cap(Mil.): $441.80
Shares Outstanding(Mil.): 103.47
Dividend: --
Yield (%): --

Financials

  CERS.OQ Industry Sector
P/E (TTM): -- 34.59 29.63
EPS (TTM): -0.64 -- --
ROI: -61.54 12.50 12.96
ROE: -76.46 14.56 14.11

BRIEF-Cerus Corp reports Q3 loss per share $0.14

* Continues to expect 2016 global product revenue in range of $37 million to $40 million

Nov 03 2016

BRIEF-Cerus announces first U.S. Blood center customer submits biologics license application

* Cerus announces first U.S. Blood center customer submits biologics license application to the FDA to allow for interstate export of intercept platelet components

Oct 13 2016

BRIEF-FDA recommends use of pathogen reduction for universal Zika risk reduction of blood components

* Fda's new recommendation for universal zika risk reduction of blood components includes use of pathogen reduction

Aug 29 2016

More From Around the Web

Competitors

  Price Chg
Terumo Corp (4543.T) ¥3,950 -25.00
Grifols SA (GRLS.MC) €20.82 -0.14
Grifols SA (GRLSbn.MC) €16.53 +0.05

Earnings vs. Estimates